Related Experiment Videos
Acetylcholine release from synaptosomes and phenytoin action.
Brain Research
|April 2, 1984
Summary
Phenytoin, an anti-epileptic drug, exhibits a dual effect on acetylcholine release from synaptosomes. It inhibits release during depolarization but enhances it in undepolarized conditions, impacting neurotransmission.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Synaptosomes are crucial for studying neurotransmitter release dynamics.
- Acetylcholine is a key neurotransmitter involved in various physiological processes.
- Understanding drug effects on neurotransmitter release is vital for neurological disorder treatment.
Purpose of the Study:
- To investigate the dual effect of phenytoin on acetylcholine release from synaptosomes.
- To determine the influence of calcium and depolarization on phenytoin's action.
- To validate the hypothesis of phenytoin's biphasic impact on neurotransmitter release.
Main Methods:
- Measurement of radiolabeled acetylcholine release from methyl-[3H]choline-loaded synaptosomes.
- Experiments conducted in Krebs-Ringer-Bicarbonate (KRB) media with varying KCl concentrations (5.6 mM and 56 mM).
- Assessment of release in the presence and absence of calcium (1.0 mM Ca or 0 Ca with 1 mM EGTA).
Main Results:
- Phenytoin (2 x 10(-4) M) reduced depolarization-dependent acetylcholine release in 1.0 mM Ca and 56 mM KCl.
- Phenytoin significantly increased acetylcholine release from undepolarized synaptosomes in 5.6 mM KCl, regardless of calcium concentration.
- No effect of phenytoin was observed on release from synaptosomes depolarized in calcium-free media.
Conclusions:
- Phenytoin demonstrates a dual effect on acetylcholine release, acting differently under depolarized and undepolarized conditions.
- The drug's impact is modulated by calcium availability and the degree of membrane depolarization.
- These findings support the hypothesis of phenytoin's complex, dose-dependent influence on synaptic transmission.